Pretreatment of synthetic vascular grafts with heparin before implantation, a simple technique to reduce the risk of thrombosis

Rabin Gerrah, Rachel E. Sunstrom PA-C, Alan (Roger) Hohimer

Research output: Contribution to journalArticle

Abstract

Thrombosis of synthetic grafts commonly used in cardiovascular surgery is a major complication. We examined whether pretreatment of the graft with heparin reduces the risk of early thrombosis. A circuit was assembled to compare two pairs of shunts simultaneously in the same animal. The study shunts were pretreated with heparin. After 2 hours of circulation, clot formation was evaluated by image analysis techniques. The pretreated grafts had fewer blood clots adhered to the surface by direct visual inspection. The image analysis showed 5 vs. 39 clots, 0.01% vs. 1.8% clotted area, and 62 vs. 5630 clot pixel area between the treated and non-treated grafts respectively, p <0.05. Pretreatment of the synthetic graft with heparin prior to implantation reduces the risk of early clot formation. This simple practice might be helpful to prevent initial thrombosis of the graft and later occlusion.

Original languageEnglish (US)
Pages (from-to)513-518
Number of pages6
JournalVascular
Volume23
Issue number5
DOIs
StatePublished - Oct 29 2015

Fingerprint

Blood Vessels
Heparin
Thrombosis
Transplants

Keywords

  • aortopulmonary shunt
  • Heparin
  • polytetrafluoroethylene
  • synthetic graft
  • thrombosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging
  • Surgery

Cite this

Pretreatment of synthetic vascular grafts with heparin before implantation, a simple technique to reduce the risk of thrombosis. / Gerrah, Rabin; Sunstrom PA-C, Rachel E.; Hohimer, Alan (Roger).

In: Vascular, Vol. 23, No. 5, 29.10.2015, p. 513-518.

Research output: Contribution to journalArticle

Gerrah, Rabin ; Sunstrom PA-C, Rachel E. ; Hohimer, Alan (Roger). / Pretreatment of synthetic vascular grafts with heparin before implantation, a simple technique to reduce the risk of thrombosis. In: Vascular. 2015 ; Vol. 23, No. 5. pp. 513-518.
@article{5dda1b59e8ab46ef9da4bf70d77269af,
title = "Pretreatment of synthetic vascular grafts with heparin before implantation, a simple technique to reduce the risk of thrombosis",
abstract = "Thrombosis of synthetic grafts commonly used in cardiovascular surgery is a major complication. We examined whether pretreatment of the graft with heparin reduces the risk of early thrombosis. A circuit was assembled to compare two pairs of shunts simultaneously in the same animal. The study shunts were pretreated with heparin. After 2 hours of circulation, clot formation was evaluated by image analysis techniques. The pretreated grafts had fewer blood clots adhered to the surface by direct visual inspection. The image analysis showed 5 vs. 39 clots, 0.01{\%} vs. 1.8{\%} clotted area, and 62 vs. 5630 clot pixel area between the treated and non-treated grafts respectively, p <0.05. Pretreatment of the synthetic graft with heparin prior to implantation reduces the risk of early clot formation. This simple practice might be helpful to prevent initial thrombosis of the graft and later occlusion.",
keywords = "aortopulmonary shunt, Heparin, polytetrafluoroethylene, synthetic graft, thrombosis",
author = "Rabin Gerrah and {Sunstrom PA-C}, {Rachel E.} and Hohimer, {Alan (Roger)}",
year = "2015",
month = "10",
day = "29",
doi = "10.1177/1708538114560455",
language = "English (US)",
volume = "23",
pages = "513--518",
journal = "Vascular",
issn = "1708-5381",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - Pretreatment of synthetic vascular grafts with heparin before implantation, a simple technique to reduce the risk of thrombosis

AU - Gerrah, Rabin

AU - Sunstrom PA-C, Rachel E.

AU - Hohimer, Alan (Roger)

PY - 2015/10/29

Y1 - 2015/10/29

N2 - Thrombosis of synthetic grafts commonly used in cardiovascular surgery is a major complication. We examined whether pretreatment of the graft with heparin reduces the risk of early thrombosis. A circuit was assembled to compare two pairs of shunts simultaneously in the same animal. The study shunts were pretreated with heparin. After 2 hours of circulation, clot formation was evaluated by image analysis techniques. The pretreated grafts had fewer blood clots adhered to the surface by direct visual inspection. The image analysis showed 5 vs. 39 clots, 0.01% vs. 1.8% clotted area, and 62 vs. 5630 clot pixel area between the treated and non-treated grafts respectively, p <0.05. Pretreatment of the synthetic graft with heparin prior to implantation reduces the risk of early clot formation. This simple practice might be helpful to prevent initial thrombosis of the graft and later occlusion.

AB - Thrombosis of synthetic grafts commonly used in cardiovascular surgery is a major complication. We examined whether pretreatment of the graft with heparin reduces the risk of early thrombosis. A circuit was assembled to compare two pairs of shunts simultaneously in the same animal. The study shunts were pretreated with heparin. After 2 hours of circulation, clot formation was evaluated by image analysis techniques. The pretreated grafts had fewer blood clots adhered to the surface by direct visual inspection. The image analysis showed 5 vs. 39 clots, 0.01% vs. 1.8% clotted area, and 62 vs. 5630 clot pixel area between the treated and non-treated grafts respectively, p <0.05. Pretreatment of the synthetic graft with heparin prior to implantation reduces the risk of early clot formation. This simple practice might be helpful to prevent initial thrombosis of the graft and later occlusion.

KW - aortopulmonary shunt

KW - Heparin

KW - polytetrafluoroethylene

KW - synthetic graft

KW - thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84942316946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942316946&partnerID=8YFLogxK

U2 - 10.1177/1708538114560455

DO - 10.1177/1708538114560455

M3 - Article

C2 - 25406265

AN - SCOPUS:84942316946

VL - 23

SP - 513

EP - 518

JO - Vascular

JF - Vascular

SN - 1708-5381

IS - 5

ER -